|
KIAA2026 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.25489984859462E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.015010E-04 |
| Normal-vs-Stage2 |
1.018020E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
2.597600E-03 |
| Stage1-vs-Stage2 |
9.551400E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
9.779200E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
9.221400E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.37360000543418E-08 |
| Normal-vs-AfricanAmerican |
1.409800E-01 |
| Normal-vs-Asian |
2.76139999999536E-06 |
| Caucasian-vs-AfricanAmerican |
9.059600E-02 |
| Caucasian-vs-Asian |
7.540200E-01 |
| AfricanAmerican-vs-Asian |
5.592400E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.51920000000172E-05 |
| Normal-vs-Female |
1.66829999999063E-05 |
| Male-vs-Female |
7.556400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.603600E-03 |
| Normal-vs-Extreme_Weight |
3.634400E-04 |
| Normal-vs-Obese |
6.838200E-04 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
3.506800E-01 |
| Normal_Weight-vs-Obese |
4.507800E-02 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
3.734000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.583400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.282800E-03 |
| Normal-vs-Age(61-80Yrs) |
5.53679999959478E-07 |
| Normal-vs-Age(81-100Yrs) |
3.343400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.429400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.881400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.528600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.129400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.503000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.386400E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
4.424200E-01 |
| Normal-vs-Grade 3 |
6.431400E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
8.497800E-01 |
| Grade 2-vs-Grade 4 |
4.424200E-01 |
| Grade 3-vs-Grade 4 |
6.431400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.5418000001235E-07 |
| Normal-vs-N1 |
6.724300E-03 |
| N0-vs-N1 |
5.256200E-01 |
|
|
